Tickers

1. Composite Trajectory Verdict

Given U's asset-light platform model with high stock-based compensation and acquired intangible amortization, the cash flow statement carries the most weight for assessing financial trajectory, though the income statement's GAAP losses and balance sheet's equity erosion from impairments and accumulated deficit are also material.

Composite Trajectory: Mixed

The annual income statement shows improvement: revenue grew 2% year-over-year to $1.85B, gross margin expanded to 74% from 73%, operating loss narrowed 37% to $479M, and net loss narrowed 40% to $401M (10-K 2025-12-31, Consolidated Statements of Operations). Quarterly Q2 2026 also shows strong improvement: revenue rose 24% YoY to $546M, gross margin jumped to 80% from 74%, and net loss narrowed to $23M from $107M (10-Q 2026-06-30, Condensed Statements of Operations). However, the six-month GAAP picture deteriorated due to $279M of impairment charges ($227M in cost of revenue, $47M in sales and marketing) from the ironSource sunset and Supersonic exit, pushing YTD gross margin down to 56% from 74% and widening YTD net loss to $370M from $185M (10-Q 2026-06-30, Condensed Statements of Operations; MD&A). Cash generation is unequivocally improving: annual operating cash flow rose to $423M from $316M, free cash flow to $404M from $286M (10-K 2025-12-31, Consolidated Statements of Cash Flows; MD&A), and YTD June 2026 operating cash flow nearly doubled to $277M from $146M with free cash flow of $268M vs $134M (10-Q 2026-06-30, Condensed Statements of Cash Flows). The balance sheet shows rising cash ($2.35B vs $2.06B) but declining equity ($3.03B vs $3.24B) as accumulated deficit deepens to $4.51B from $4.14B, intangible assets dropped to $163M from $651M after impairments, and the $557M current portion of 2026 Notes matures in November 2026 (10-Q 2026-06-30, Condensed Balance Sheets; Note 6).

2. Red Flags

• Large recurring "non-recurring" impairments: $279M impairment in Q1 2026 (ironSource/Supersonic) follows $77M intangible useful-life change in 2025 and $5.9M/$22.8M property/equipment impairments in 2025/2024 (10-Q 2026-06-30, Note 1; 10-K 2025-12-31, Note 1, Note 7).
• GAAP vs. non-GAAP divergence widening: FY 2025 GAAP net loss $401M vs. adjusted EBITDA $409M; YTD June 2026 GAAP net loss $370M vs. Q2 adjusted EBITDA $160M (quarterly YTD adjusted EBITDA not disclosed) (10-K 2025-12-31, MD&A; 10-Q 2026-06-30, MD&A).
• Accumulated deficit accelerating: Grew $371M in first half of 2026 alone vs. $403M in all of 2025, reaching $4.51B (10-Q 2026-06-30, Condensed Balance Sheets; 10-K 2025-12-31, Consolidated Balance Sheets).
• Stockholders' equity declining despite cash growth: Equity fell $204M in six months while cash rose $296M, driven by net losses and $11M redeemable noncontrolling interest accretion (10-Q 2026-06-30, Condensed Balance Sheets; Condensed Statements of Stockholders' Equity).
• Near-term debt maturity: $557M of 2026 Notes classified as current, maturing November 2026; company states intent to repay with cash (10-Q 2026-06-30, Note 6; MD&A).
• Revenue concentration and strategic shift: Unity Ad Network 56% and IronSource 11% of Grow Solutions in Q4 2025; IronSource now being sunset, Supersonic sold August 2026 (10-K 2025-12-31, MD&A; 10-Q 2026-06-30, MD&A).
• Valuation allowance on deferred tax assets growing: $1.26B vs $1.17B, with $1.37B gross deferred assets largely unrecognized (10-K 2025-12-31, Note 13).

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Mixed

Annual GAAP results improved: revenue increased 2% to $1.85B, gross margin expanded 100 bps to 74%, total operating expenses fell 11% to $1.85B, operating loss narrowed 37% to $479M, and net loss narrowed 40% to $401M (10-K 2025-12-31, Consolidated Statements of Operations). Q2 2026 showed strong core improvement: revenue up 24% YoY to $546M, gross margin up 600 bps to 80%, operating loss narrowed 73% to $32M, net loss narrowed 79% to $23M (10-Q 2026-06-30, Condensed Statements of Operations). However, six-month GAAP results deteriorated sharply due to $279M impairment charges: YTD revenue rose 20% to $1.05B but gross margin collapsed to 56% from 74%, operating loss widened 56% to $384M, and net loss doubled to $370M from $185M (10-Q 2026-06-30, Condensed Statements of Operations). Non-GAAP adjusted EBITDA improved annually to $409M from $390M and quarterly to $160M from $90M, but adjusted EPS dipped annually to $0.86 from $0.89 (10-K 2025-12-31, MD&A; 10-Q 2026-06-30, MD&A).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Improving

Operating cash flow has grown consistently: $235M (2023) → $316M (2024) → $423M (2025) annually, and YTD June 2026 reached $277M vs $146M in YTD June 2025 (+89%) (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Condensed Statements of Cash Flows). Free cash flow mirrored this: $286M (2024) → $404M (2025) annually, and $268M vs $134M for the comparable six-month periods (+100%) (10-K 2025-12-31, MD&A; 10-Q 2026-06-30, MD&A). Cash and equivalents rose from $1.52B (Dec 2024) to $2.06B (Dec 2025) to $2.35B (June 2026) (10-K 2025-12-31, Consolidated Balance Sheets; 10-Q 2026-06-30, Condensed Balance Sheets). Investing outflows remain minimal ($19M capex in 2025, $8.5M YTD June 2026). Financing in 2025 included $690M 2030 Notes issuance and $642M 2026 Notes repurchase; YTD 2026 financing was neutral at $16M from equity plans (10-K 2025-12-31, Consolidated Statements of Cash Flows; 10-Q 2026-06-30, Condensed Statements of Cash Flows).

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Liquidity strengthened: cash grew to $2.35B (June 2026) from $2.06B (Dec 2025) and $1.52B (Dec 2024); current assets rose to $3.18B from $2.81B (10-Q 2026-06-30, Condensed Balance Sheets; 10-K 2025-12-31, Consolidated Balance Sheets). Total assets declined to $6.66B from $6.84B due to $487M drop in intangible assets (from $651M to $163M) after $271M impairment and accelerated amortization, and $11M goodwill reduction (10-Q 2026-06-30, Condensed Balance Sheets; Note 1). Total liabilities roughly flat at $3.35B vs $3.34B; convertible notes stable at $2.24B net carrying amount, with $557M current portion due November 2026 (10-Q 2026-06-30, Condensed Balance Sheets; Note 6). Stockholders' equity fell to $3.03B from $3.24B as accumulated deficit deepened to $4.51B from $4.14B; redeemable noncontrolling interest rose to $267M from $253M (10-Q 2026-06-30, Condensed Balance Sheets; Condensed Statements of Stockholders' Equity). Working capital improved: current assets $3.18B vs current liabilities $1.57B (10-Q 2026-06-30, Condensed Balance Sheets).

6. Data Gaps

• Standalone Q1 2026 income statement (only YTD and Q2 provided in 10-Q 2026-06-30)
• Standalone Q3 2025 and Q4 2025 income statements (only full-year in 10-K 2025-12-31)
• Quarterly non-GAAP adjusted EBITDA and adjusted EPS for Q1 2026 and YTD June 2026
• Quarterly free cash flow for Q2 2026 standalone (only YTD provided)
• Detailed revenue breakdown for non-strategic portfolio by quarter prior to Q2 2026
• Segment-level profitability (company reports single segment)
• Cash flow statement for standalone Q2 2026 (only YTD provided)
• Full 10-Q filings for 2026-03-31, 2025-09-30, 2025-06-30 (referenced but not in provided text)